Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 12 Mar 2026. The item focuses on Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study. Review the original article for the full source wording and details.
Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 12 Mar 2026.
The item focuses on Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study.
Review the original article for the full source wording and details.